Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Depreciation & Amortization (CF) (2020 - 2025)

Agilon Health's Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $7.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 7.31% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $28.6 million, up 16.89%, while the annual FY2025 figure was $28.6 million, 16.89% up from the prior year.
  • Depreciation & Amortization (CF) reached $7.0 million in Q4 2025 per AGL's latest filing, down from $7.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.4 million in Q3 2025 to a low of $3.0 million in Q2 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $5.1 million, with a median of $5.2 million recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): fell 15.83% in 2022, then soared 81.3% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $3.6 million in 2021, then rose by 7.39% to $3.9 million in 2022, then skyrocketed by 31.74% to $5.1 million in 2023, then increased by 26.17% to $6.5 million in 2024, then rose by 7.31% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Depreciation & Amortization (CF) are $7.0 million (Q4 2025), $7.4 million (Q3 2025), and $7.3 million (Q2 2025).